Identification and Validation of a Metabolism-related Gene Signature for Predicting the Prognosis of Paediatric Medulloblastoma

Overview

Journal Sci Rep

Specialty Science

Date 2024 Mar 30

PMID 38553479

Authors

Jun Su

Qin Xie

Longlong Xie

Affiliations

Soon will be listed here.

Abstract

Medulloblastoma (MB) is a malignant brain tumour that is highly common in children and has a tendency to spread to the brain and spinal cord. MB is thought to be a metabolically driven brain tumour. Understanding tumour cell metabolic patterns and characteristics can provide a promising foundation for understanding MB pathogenesis and developing treatments. Here, by analysing RNA-seq data of MB samples from the Gene Expression Omnibus (GEO) database, 12 differentially expressed metabolic-related genes (DE-MRGs) were chosen for the construction of a predictive risk score model for MB. This model demonstrated outstanding accuracy in predicting the outcomes of MB patients and served as a standalone predictor. An evaluation of functional enrichment revealed that the risk score showed enrichment in pathways related to cancer promotion and the immune response. In addition, a high risk score was an independent poor prognostic factor for MB in patients with different ages, sexes, metastasis stages and subgroups (SHH and Group 4). Consistently, the metabolic enzyme ornithine decarboxylase (ODC1) was upregulated in MB patients with poor survival time. Inhibition of ODC1 in primary and metastatic MB cell lines decreased cell proliferation, migration and invasion but increased immune infiltration. This study could aid in identifying metabolic targets for MB as well as optimizing risk stratification systems and individual treatment plans for MB patients via the use of a metabolism-related gene prognostic risk score signature.

Citing Articles

Identification and validation of miRNA-target genes network in pediatric brain tumors.

Gruszka R, Zakrzewski J, Nowoslawska E, Grajkowska W, Zakrzewska M Sci Rep. 2024; 14(1):17922.

PMID: 39095557 PMC: 11297236. DOI: 10.1038/s41598-024-68945-z.

Hedgehog pathway and cancer: A new area (Review).

Shen D, Xia Y, Fu Y, Cao Q, Chen W, Zhu Y Oncol Rep. 2024; 52(3).

PMID: 38994763 PMC: 11267502. DOI: 10.3892/or.2024.8775.

References

Cervelli M, Pietropaoli S, Signore F, Amendola R, Mariottini P . Polyamines metabolism and breast cancer: state of the art and perspectives. Breast Cancer Res Treat. 2014; 148(2):233-48. DOI: 10.1007/s10549-014-3156-7. View

Kimura R, Kasamatsu A, Koyama T, Fukumoto C, Kouzu Y, Higo M . Glutamate acid decarboxylase 1 promotes metastasis of human oral cancer by β-catenin translocation and MMP7 activation. BMC Cancer. 2013; 13:555. PMC: 3866561. DOI: 10.1186/1471-2407-13-555. View

Tsuboi M, Kondo K, Masuda K, Tange S, Kajiura K, Kohmoto T . Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma. Cancer Med. 2019; 8(9):4189-4199. PMC: 6675743. DOI: 10.1002/cam4.2345. View

Nie Y, Liu L, Liu Q, Zhu X . Identification of a metabolic-related gene signature predicting the overall survival for patients with stomach adenocarcinoma. PeerJ. 2021; 9:e10908. PMC: 7877239. DOI: 10.7717/peerj.10908. View

Tech K, Deshmukh M, Gershon T . Adaptations of energy metabolism during cerebellar neurogenesis are co-opted in medulloblastoma. Cancer Lett. 2014; 356(2 Pt A):268-72. PMC: 4141892. DOI: 10.1016/j.canlet.2014.02.017. View

Tech K, Gershon T . Energy metabolism in neurodevelopment and medulloblastoma. Transl Pediatr. 2016; 4(1):12-9. PMC: 4729065. DOI: 10.3978/j.issn.2224-4336.2015.01.03. View

Zhang D, Yang N . MiR-3174 functions as an oncogene in rectal cancer by targeting PCBD2. Eur Rev Med Pharmacol Sci. 2019; 23(6):2417-2426. DOI: 10.26355/eurrev_201903_17388. View

Gururangan S, Hwang E, Herndon 2nd J, Fuchs H, George T, Coleman R . [18F]fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma. Neurosurgery. 2004; 55(6):1280-8. DOI: 10.1227/01.neu.0000143027.41632.2b. View

Evageliou N, Hogarty M . Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma. Clin Cancer Res. 2009; 15(19):5956-61. PMC: 2923453. DOI: 10.1158/1078-0432.CCR-08-3213. View

10.

Wu H, He G, Song T, Zhang Y, Chen X, Chen H . Evaluation of GALNT16 polymorphisms to breast cancer risk in Chinese population. Mol Genet Genomic Med. 2019; 7(8):e848. PMC: 6687646. DOI: 10.1002/mgg3.848. View

11.

Gamble L, Purgato S, Murray J, Xiao L, Yu D, Hanssen K . Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma. Sci Transl Med. 2019; 11(477). DOI: 10.1126/scitranslmed.aau1099. View

12.

Park A, Lee J, Cheong H, Ramaswamy V, Park S, Kool M . Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma. BMC Cancer. 2019; 19(1):571. PMC: 6560914. DOI: 10.1186/s12885-019-5742-x. View

13.

Tanadi C, Bambang A, Wendi I, Sidharta V, Hananta L, Sumarpo A . The predictive value of PRDM2 in solid tumor: a systematic review and meta-analysis. PeerJ. 2020; 8:e8826. PMC: 7195840. DOI: 10.7717/peerj.8826. View

14.

Guo Y, Huang P, Ning W, Zhang H, Yu C . Identification of Core Genes and Pathways in Medulloblastoma by Integrated Bioinformatics Analysis. J Mol Neurosci. 2020; 70(11):1702-1712. DOI: 10.1007/s12031-020-01556-1. View

15.

Liao W, Yen H, Liao C, Tseng T, Lan C, Liu C . DSE regulates the malignant characters of hepatocellular carcinoma cells by modulating CCL5/CCR1 axis. Am J Cancer Res. 2019; 9(2):347-362. PMC: 6405965. View

16.

Zhang H, Zhang L, Yang C, Li J, Tian X, Li D . The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling. PLoS One. 2021; 16(2):e0245876. PMC: 7877577. DOI: 10.1371/journal.pone.0245876. View

17.

Wei D, Yiyuan C, Qian L, Jianhua L, Yazhuo Z, Hua G . The absence of PRDM2 involved the tumorigenesis of somatotroph adenomas through regulating c-Myc. Gene. 2020; 737:144456. DOI: 10.1016/j.gene.2020.144456. View

18.

Kubo S, Tamori A, Tanaka H, Takemura S, Shuto T, Hirohashi K . Polyamine metabolism and recurrence after resection for hepatocellular carcinoma. Hepatogastroenterology. 2004; 51(55):208-10. View

19.

Zhuang S, Li L, Zang Y, Li G, Wang F . RRM2 elicits the metastatic potential of breast cancer cells by regulating cell invasion, migration and VEGF expression via the PI3K/AKT signaling. Oncol Lett. 2020; 19(4):3349-3355. PMC: 7074627. DOI: 10.3892/ol.2020.11428. View

20.

DAmico D, Antonucci L, Di Magno L, Coni S, Sdruscia G, Macone A . Non-canonical Hedgehog/AMPK-Mediated Control of Polyamine Metabolism Supports Neuronal and Medulloblastoma Cell Growth. Dev Cell. 2015; 35(1):21-35. PMC: 4607931. DOI: 10.1016/j.devcel.2015.09.008. View